[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immucell Corp (ICCC)

Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,515
  • Shares Outstanding, K 9,047
  • Annual Sales, $ 27,640 K
  • Annual Income, $ -1,040 K
  • EBIT $ 3 M
  • EBITDA $ 5 M
  • 60-Month Beta 0.54
  • Price/Sales 3.61
  • Price/Cash Flow 57.16
  • Price/Book 3.42

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.50 +4.09%
on 08/05/26
12.10 -9.67%
on 07/14/26
+0.04 (+0.37%)
since 07/10/26
3-Month
8.11 +34.69%
on 05/11/26
12.10 -9.67%
on 07/14/26
+2.88 (+35.78%)
since 05/08/26
52-Week
4.52 +141.81%
on 11/21/25
12.10 -9.67%
on 07/14/26
+4.27 (+64.11%)
since 08/08/25

Most Recent Stories

More News
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets...

ICCC : 10.97 (-0.27%)
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

PORTLAND, Maine, July 09, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets...

ICCC : 10.97 (-0.27%)
ImmuCell Q1 Earnings Call Highlights

ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever quarter...

ICCC : 10.97 (-0.27%)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to...

ICCC : 10.97 (-0.27%)
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026

PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve...

ICCC : 10.97 (-0.27%)
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to...

ICCC : 10.97 (-0.27%)
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets...

ICCC : 10.97 (-0.27%)
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets...

ICCC : 10.97 (-0.27%)
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products...

ICCC : 10.97 (-0.27%)
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products...

ICCC : 10.97 (-0.27%)

Business Summary

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM,...

See More

Key Turning Points

3rd Resistance Point 11.37
2nd Resistance Point 11.20
1st Resistance Point 11.10
Last Price 10.97
1st Support Level 10.83
2nd Support Level 10.66
3rd Support Level 10.56

See More

52-Week High 12.10
Last Price 10.97
Fibonacci 61.8% 9.20
Fibonacci 50% 8.31
Fibonacci 38.2% 7.42
52-Week Low 4.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.